2007 Schedule & Presentations

Thursday, February 15, 2007:

7:30 – 8:30 a.m.         Breakfast and Registration
8:30 – 8:45 a.m.         Seating

THROMBOSIS PREVENTION:

8:45 a.m.                    Welcome:  Arthur A. Sasahara, MD
8:55 a.m.                    Opening Remarks:  Samuel Z. Goldhaber, MD

(Moderators: Arthur Sasahara, MD and Samuel Z. Goldhaber, MD)

Prevention: Current Perspectives

9:00 - 9:20 a.m.          Patient Advocacy and The United States Congress
                                Geno Merli, MD
9:20 – 9:25 a.m.         Discussion

9:25 – 9:45 a.m.         Patient Advocacy: How to Work With UK Parliament
                                Ajay Kakkar, MD
9:45 – 9:50 a.m.         Discussion

9:50 – 10:10 a.m.       Prevention of VTE Among Hospitalized Patients:
Human Alerts vs. Electronic Alerts—Are We Better Off Notifying the Attending Physician or the Intern?   Samuel Z. Goldhaber, MD     
10:10 – 10:15 a.m.      Discussion

10:15 - 10:35 a.m.      Anticoagulation Armamentarium: Update on Drugs and Mechanisms - Sudha Parasuraman, MD 
10:35 – 10:40 a.m.     Discussion

10:40 – 11:00 a.m.     Outpatient Treatment of VTE
                               Sylvia McKean, MD
11:00 – 11:05 a.m.     Discussion
           
11:05 – 11:20 a.m.     COFFEE BREAK

Therapeutic Targets and Approaches

11:20 - 11:40 a.m.     Hospital Pharmacists and DVT Prevention During Hospitalization and at the Time of Hospital Discharge: A Patient Safety Issue  - John Fanikos, RPh, MBA  
11:40 - 11:45 a.m.     Discussion

11:45 - 12:05 p.m.     Implications of an Out-of-Range INR: Bleeding and Clotting Complications - Elaine Hylek, MD             
12:05 - 12:10 p.m.     Discussion

12:10 - 12:30 p.m.     Warfarin Genetics and Dosing: The New Pharmacogenomic Frontier - Samuel Z. Goldhaber, MD
12:30 - 12:35 p.m.     Discussion

12:35 – 12:50 p.m.     Substituting Generic Drugs for Brand Name Drugs
                               Jawed Fareed, PhD
12:50 – 12:55 p.m.     Discussion

12:55 - 2:00 p.m.       LUNCH

PREVENTION BREAK OUT SESSIONS:

Each session is 45 minutes long and repeated 3 times.

2:00 - 4:45 p.m.        Break Out Sessions I / II / III:

Session I: How to Run an Anticoagulation Service                
Erin Oliver, PA-C
Mary Kay Kleinschmidt, PA-C
Cheryl Silva, PharmD
Nicole Grasso-Correnti, RN, BSN

Session II: Knowledge Is Power: Patient Advocacy   
Samuel Z. Goldhaber, MD – NATF
Ruth B. Morrison, RN – PE SUPPORT GROUP
Mark Jablonski – President, NATT
Michael Hefron – DVT Patient, NATT
Lisa Kory – PE Patient

Session III: VTE Prevention: Making the Evidence Based Guidelines “Come Alive” and Transitioning from Voluntary Adherence to Mandatory Enforcement
Sylvia McKean, MD
John Fanikos, RPh, MBA

 

2007 Course Presentations

1:  Patient Advocacy and the United States Congress
      Geno Merli, MD
      Merli_Summary                               Merli_Slides

2:   Patient Advocacy and the British Parliament
      Ajay K. Kakkar, MD, PhD
      Kakkar_Summary                            Kakkar_Slides

3:   Human Alerts vs. Electronic Alerts
      Karen Fiumara, PharmD
      Fiumara_Summary                           Fiumara_Slides

4.   Anticoagulation Armamentarium: Update on Drugs and Mechanisms
      Sudha Parasuraman, MD
      Parasuraman_Summary                  Parasuraman_Slides

5.   Outpatient Treatment of Venous Thromboembolism
      Sylvia McKean, MD
      McKean_Summary                          McKean_Slides

6.   Hospital Pharmacists and DVT Prevention During Hospitalization and at the Time of Hospital Discharge:  A Patient Safety Issue
      John Fanikos, RPh, MBA
      Fanikos_Summary                          Fanikos_Slides

7.   Implications of an Out-of-Range INR: Bleeding and Clotting Complications
      Elaine Hylek, MD
      Hylek_Summary                              Hylek_Slides

8.   Warfarin Genetics and Dosing:  The New Pharmacogenomic Frontier
      Samuel Z. Goldhaber, MD
      Goldhaber_Summary                      Goldhaber_Slides

9.   Substituting Generic Drugs for Brand Name Drugs
      Jawed Fareed, PhD
      Fareed_Summary                            Fareed_Slides

 

 
 

Terms of Use and Privacy Policy